Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seres Therapeutics Inc
(NQ:
MCRB
)
0.5842
-0.0431 (-6.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Seres Therapeutics Inc
< Previous
1
2
3
4
5
Next >
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
March 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Gold Price Alert: Gold Spot Prices Just Hit a Record High Today
March 05, 2024
Investors in gold are excited on Tuesday as the spot price of the precious metal hit a recent high of $2,113.28 per ounce during a rally.
Via
InvestorPlace
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023
March 05, 2024
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?
January 09, 2024
Seres Therapeutics Inc (NASDAQ: MCRB) received FDA Fast Track Designation for SER-155, an investigational oral, cultivated microbiome therapeutic designed to prevent GI-associated bacterial infections...
Via
Benzinga
Exposures
Product Safety
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
January 09, 2024
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Outlook For Seres Therapeutics
November 01, 2023
Via
Benzinga
Earnings Outlook For Seres Therapeutics
August 07, 2023
Via
Benzinga
Looking Into Seres Therapeutics's Return On Capital Employed
May 24, 2023
Via
Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Seres Therapeutics's Earnings: A Preview
March 04, 2024
Via
Benzinga
Preview: Seres Therapeutics's Earnings
May 08, 2023
Via
Benzinga
Where Seres Therapeutics Stands With Analysts
April 28, 2023
Via
Benzinga
Why Seres Therapeutics Shares Are Surging Thursday Morning
April 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Nasdaq Gains 1%; US Adds 150,000 Jobs In October
November 03, 2023
U.S. stocks traded higher this morning, following the release of jobs report for October. Following the market opening Friday, the Dow traded up 0.50% to 34,009.36 while the NASDAQ rose 1% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
April 20, 2023
These two biotech stocks might be significantly undervalued.
Via
The Motley Fool
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Via
Benzinga
Seres Therapeutics' Q2 Revenues Top Estimates; Reports Encouraging VOWST Early Commercial Uptake
August 08, 2023
Seres Therapeutics, Inc. (NASDAQ: MCRB) reported Q2 revenues of $126.47 million,
Via
Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
August 08, 2023
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
'Walk Away From It': Jim Cramer On This US Telecom Service Provider
July 25, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said AT&T Inc. (NYSE: T) is "as poorly managed as any company I’ve ever seen in my lifetime." He added,
Via
Benzinga
Mastercard To Rally Over 18%? Here Are 10 Other Analyst Forecasts For Friday
April 28, 2023
Wells Fargo raised the price target for Molina Healthcare, Inc. (NYSE: MOH) from $282 to $290. Wells Fargo analyst Stephen Baxter maintained an Underweight rating. Molina Healthcare shares gained 7.8%...
Via
Benzinga
Snap, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 28, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Tesla, Meta Platforms, Seres Therapeutics, Atomera, Roku: Why These 5 Stocks Are Drawing Investors' Attention Today
April 26, 2023
Via
Benzinga
Amazon, Microsoft, Alphabet And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
April 26, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
April 21, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
April 04, 2023
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.